Researchers develop nanoparticles delivering STING agonists for intravenous cancer immunotherapy

By | October 1, 2021
Cancer immunotherapy seeks to turn “cold” tumors into “hot” tumors––those that respond to immunotherapy––by awakening and enlisting the body’s own immune system.